PARD6A

Chr 16

par-6 family cell polarity regulator alpha

Also known as: PAR-6A, PAR6, PAR6C, PAR6alpha, TAX40, TIP-40

The protein functions as an adapter protein that controls asymmetrical cell division, cell polarization, and centrosome organization by linking GTP-bound Rho small GTPases to atypical protein kinase C proteins and recruiting key centrosomal proteins that regulate microtubule organization. Mutations in PARD6A cause disease through a gain-of-function mechanism, though specific associated neurological conditions are not established in the provided data. The gene shows tolerance to loss-of-function variants (pLI 0.006, LOEUF 1.016), consistent with the gain-of-function disease mechanism.

Summary from RefSeq, UniProt, Mechanism
Research Assistant →
0
Active trials
2
Pubs (1 yr)
28
P/LP submissions
0%
P/LP missense
1.02
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryPARD6A
Population Constraint (gnomAD)
Low constraint (pLI 0.01) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
28 unique Pathogenic / Likely Pathogenic· 44 VUS of 83 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.02LOEUF
pLI 0.006
Z-score 1.54
OE 0.48 (0.251.02)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
1.69Z-score
OE missense 0.69 (0.610.79)
162 obs / 235.1 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.48 (0.251.02)
00.351.4
Missense OE0.69 (0.610.79)
00.61.4
Synonymous OE0.87
01.21.6
LoF obs/exp: 5 / 10.3Missense obs/exp: 162 / 235.1Syn Z: 1.04
DN
0.74top 25%
GOF
0.74top 25%
LOF
0.3940th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

83 submitted variants in ClinVar

Classification Summary

Pathogenic25
Likely Pathogenic3
VUS44
Likely Benign3
Benign2
25
Pathogenic
3
Likely Pathogenic
44
VUS
3
Likely Benign
2
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
25
0
25
Likely Pathogenic
0
0
3
0
3
VUS
0
37
7
0
44
Likely Benign
0
1
0
2
3
Benign
0
1
0
1
2
Total03935377

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

PARD6A · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Key Publications
Landmark & review papers · by relevance
PubMed
Top 2 results · since 2015Search PubMed ↗
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC